IDBS Polar and bioanalytical data capture: an interview with Todd Stawicki and Kevin Tse
In this interview, Todd Stawicki (Lead Product Manager, IDBS, IL, USA) and Kevin Tse (Account Manager, IDBS, MA, USA) discuss IDBS Polar and how it allows scientists to collect and seamlessly contextualize their data, essentially allowing researchers to do more with less. Stawicki also comments on how IDBS Polar isn’t tied to one therapeutic modality, meaning it is very adaptable. They talk about the key industry trends that they are most excited about, including gene and cell therapy and AI. Tse concludes by addressing the biggest pain points in bioanalytical data capture, emphasizing how most scientists want to make reporting easier for bioanalytical studies and how important it is to be able to summarize data from different places.
Questions discussed:
- In a couple of words, please articulate how IDBS Polar can assist a bioanalytical lab?
- What trends are you most excited about in our industry?
- What are the biggest pain points that you have seen in bioanalytical data capture, analysis and reporting and how has IDBS Polar helped to relieve these?
- What are the biggest challenges in the digital transformation journey?
For more information, visit IDBS‘ website!
In association with
